Appointment of Chief Executive Officer
20 October 2023
Dispensa Group plc ("Dispensa" or the "Company")
Appointment of CEO
Dispensa Group plc (LON: DISP), the holding company developing a portfolio of international luxury food brands, is pleased to announce the appointment of Mr Alessandro Colombo as CEO with immediate effect.
Mr Colombo, 56, is a highly experienced executive who has held senior leadership positions within both public and private companies as General Manager and CEO. Most recently, Mr Colombo was the Area General Manager for Italy at Sonder, a leading hospitality group, where he was responsible for strategy and operations as well as delivering record revenue growth. Prior to this, Mr Colombo was Chief Executive Officer at IKB Corporate Lab, a joint-venture between UniCredit and IKB in the financial sector, and a Vice President in investment banking at Credit Suisse First Boston, where he advised corporate clients on corporate strategy, M&A and fundraisings. Mr Colombo has also worked as a corporate finance manager at Swiss insurance company, Assura S.A. and as a management consultant for McKinsey & Co.
An Italian national, Mr Colombo speaks five languages, and has experience of working across mainland Europe and in the UK. He holds a degree in Economics from Bocconi and an MBA from the University of California, Los Angeles.
Mr Colombo's current and past directorships are as follows:
|
Current |
Past five years |
|
None |
Sonder Italy S.r.l., special attorney (legal representative) from 10/12/2018 until 30/06/2023, Director from 28/10/2019 until 21/11/2019. |
Save for the information given above, there is no further information relating to Mr Colombo required to be disclosed under the listing requirements of the London Stock Exchange.
Niccolò Caderni, Chairman of Dispensa commented; "I am delighted that Alessandro is joining the Dispensa Group as we continue to build our portfolio of luxury food brands. Alessandro brings a wealth of commercial experience which will be important as we drive growth in our group, both organically and by acquisition".
|
Dispensa Group plc |
|
|
Dr Niccolò Caderni Alessandro Colombo |
|
|
|
|
|
VSA Capital |
+44(0)20 3005 5000 |
|
Andrew Raca, Alexander Cabral (Corporate Finance) Peter Mattsson (Corporate Broking) |
|
|
Walbrook PR Limited |
+44 20 7933 8780 or +44 07768 807631 |
|
Paul Vann/Nick Rome/Joe Walker
|
dispensa@walbrookpr.com
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 3 hours ago Galantas Gold Corp.
- 3 hours ago Legal & General Group
- 3 hours ago Inchcape
- 4 hours ago Elementis
- 4 hours ago Taylor Maritime Investments Limited NPV